Squamous trans-differentiation of pancreatic cancer cells promotes stromal inflammation
Published version
Peer-reviewed
Repository URI
Repository DOI
Type
Change log
Authors
Abstract
A highly aggressive subset of pancreatic ductal adenocarcinomas undergo trans-differentiation into the squamous lineage during disease progression. Here, we investigated whether squamous trans-differentiation of human and mouse pancreatic cancer cells can influence the phenotype of non-neoplastic cells in the tumor microenvironment. Conditioned media experiments revealed that squamous pancreatic cancer cells secrete factors that recruit neutrophils and convert pancreatic stellate cells into cancer-associated fibroblasts (CAFs) that express inflammatory cytokines at high levels. We use gain- and loss-of-function approaches to show that squamous-subtype pancreatic tumor models become enriched with neutrophils and inflammatory CAFs in a p63-dependent manner. These effects occur, at least in part, through p63-mediated activation of enhancers at pro-inflammatory cytokine loci, which includes IL1A and CXCL1 as key targets. Taken together, our findings reveal enhanced tissue inflammation as a consequence of squamous trans-differentiation in pancreatic cancer, thus highlighting an instructive role of tumor cell lineage in reprogramming the stromal microenvironment.
Description
Funder: Pershing Square Foundation; FundRef: http://dx.doi.org/10.13039/100010304
Funder: Lustgarten Foundation; FundRef: http://dx.doi.org/10.13039/100005979
Funder: The Cold Spring Harbor Laboratory and Northwell Health Affiliation
Funder: Thompson Family Foundation
Funder: Simons Foundation; FundRef: http://dx.doi.org/10.13039/100000893
Keywords
Journal Title
Conference Name
Journal ISSN
Volume Title
Publisher
Publisher DOI
Sponsorship
National Cancer Institute (5P01CA013106-Project 4)
National Cancer Institute (CA229699)
Pancreatic Cancer Action Network (16-20-25-VAKO)
National Cancer Institute (5P30CA45508)
National Cancer Institute (5P50CA101955)
National Cancer Institute (P20CA192996)
National Cancer Institute (U10CA180944)
National Cancer Institute (U01CA210240)
National Cancer Institute (U01CA224013)
National Cancer Institute (1R01CA188134)
National Cancer Institute (1R01CA190092)
State of New York (C150158)
Human Frontier Science Program (LT000195/2015 L)
EMBO (ALTF 1203–2014)
Deutsche Forschungsgemeinschaft (DA 2249/1–1)
Deutsche Forschungsgemeinschaft (KL 3228/1–1)